Archive for April 2017
Disclaimers in Advertising and Labeling: What Do They Do? Who Does What?
By Mark Land, AAHP President The FTC has long recognized that marketing claims may include additional explanatory information to prevent the claims from being misleading. This is FTC’s way of…
Read MoreUnited States Food and Drug Administration Office of Pharmaceutical Quality
By Mark Land, AAHP President May 1, 2017 The Office of Pharmaceutical Quality (OPQ), created in Jan. 2015, enhances the U.S. Food and Drug Administration Center for Drug Evaluation and…
Read MoreAAHP Recognized as Voice of Homeopathy on Capitol Hill
MILWAUKIE, Ore., Apr. 10, 2017 — The American Association of Homeopathic Pharmacists’ (AAHP) Legal & Regulatory Committee recently received the 2017 Henry N. Williams Professional Service Award from the National…
Read MoreBe Prepared: Media Basics for the Non-PR Expert
By Alissa Gould, public relations manager, Boiron USA April 1, 2017 As more people discover the benefits of homeopathic medicines, our industry may become a larger target for skeptics or…
Read MoreFDA Office of Surveillance and Epidemiology
By Mark Land, AAHP President April 1, 2017 FDA’s Office of Surveillance and Epidemiology (OSE) is positioned within the Center for Drug Evaluation and Research (CDER). OSE evaluates the safety…
Read More